Oskar Bergengren1, Hans Garmo2, Ola Bratt3, Lars Holmberg4, Eva Johansson4, Anna Bill-Axelson4. 1. Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden. Electronic address: oskar.bergengren@akademiska.se. 2. Regional Cancer Centre Uppsala Örebro, Uppsala University Hospital, Uppsala, Sweden. 3. Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 4. Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
Abstract
BACKGROUND: Information about how men with prostate cancer (PC) experience their medical care and factors associated with their overall satisfaction with care (OSC) is limited. OBJECTIVE: To investigate OSC and factors associated with OSC among men with low-risk PC. DESIGN, SETTING, AND PARTICIPANTS: Men registered in the National Prostate Cancer Register of Sweden as diagnosed in 2008 with low-risk PC at the age of ≤70 yr who had undergone radical prostatectomy (RP), radiotherapy (RT), or started on active surveillance (AS) were invited in 2015 to participate in this nationwide population-based survey (n=1720). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: OSC data were analysed using ordinal logistic regression. Odds ratios (ORs) were calculated for comparisons between the highest and lowest possible response categories. RESULTS AND LIMITATIONS: A total of 1288 men (74.9%) responded. High OSC was reported by 958 (74.4%). Factors associated with high OSC were high participation in decision-making (OR 4.18, 95% confidence interval [CI] 2.61-6.69), receiving more information (OR 11.1, 95% CI 7.97-15.6), high-quality information (OR 7.85, 95% CI 5.46-11.3), access to a nurse navigator (OR 1.80, 95% CI 1.44-2.26), and better functional outcomes (defined as 25 points higher on the EPIC-26 questionnaire; OR 1.34, 95% CI 1.21-1.48). OSC was not affected by whether a doctor or specialist nurse conducted follow-up (OR 0.84, 95% CI 0.66-1.07). These findings were similar across treatment groups. Men who had undergone RP or RT reported high OSC more often than men on AS (78.2% vs 84.0% vs 72.6%), high participation in decision-making (70.5% vs 64.5% vs 49.2%), and having received more information (40.5% vs 45.8% vs 28.6%), and were less likely to believe they would die from PC (3.8% vs 3.9% vs 8.0%). Limitations include the nonrandomised retrospective design and potential recall bias. CONCLUSIONS: Information and participation in decision-making, as well as access to a nurse navigator, are key factors for OSC, regardless of treatment. Men on AS need more information about their treatment and need to participate more in decision-making. OSC was as high among men who had nurse-led follow-up as among men who had doctor-led follow-up. PATIENT SUMMARY: Information about how men with low-risk prostate cancer experience their medical care is limited. In this nationwide population-based study we found that information and participation in decision-making as well as access to a nurse navigator are key factors for satisfaction regardless of treatment. Men who are being closely watched for prostate cancer without immediate curative treatment need more information than they now receive and need to participate more in decision-making than they currently do.
BACKGROUND: Information about how men with prostate cancer (PC) experience their medical care and factors associated with their overall satisfaction with care (OSC) is limited. OBJECTIVE: To investigate OSC and factors associated with OSC among men with low-risk PC. DESIGN, SETTING, AND PARTICIPANTS: Men registered in the National Prostate Cancer Register of Sweden as diagnosed in 2008 with low-risk PC at the age of ≤70 yr who had undergone radical prostatectomy (RP), radiotherapy (RT), or started on active surveillance (AS) were invited in 2015 to participate in this nationwide population-based survey (n=1720). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: OSC data were analysed using ordinal logistic regression. Odds ratios (ORs) were calculated for comparisons between the highest and lowest possible response categories. RESULTS AND LIMITATIONS: A total of 1288 men (74.9%) responded. High OSC was reported by 958 (74.4%). Factors associated with high OSC were high participation in decision-making (OR 4.18, 95% confidence interval [CI] 2.61-6.69), receiving more information (OR 11.1, 95% CI 7.97-15.6), high-quality information (OR 7.85, 95% CI 5.46-11.3), access to a nurse navigator (OR 1.80, 95% CI 1.44-2.26), and better functional outcomes (defined as 25 points higher on the EPIC-26 questionnaire; OR 1.34, 95% CI 1.21-1.48). OSC was not affected by whether a doctor or specialist nurse conducted follow-up (OR 0.84, 95% CI 0.66-1.07). These findings were similar across treatment groups. Men who had undergone RP or RT reported high OSC more often than men on AS (78.2% vs 84.0% vs 72.6%), high participation in decision-making (70.5% vs 64.5% vs 49.2%), and having received more information (40.5% vs 45.8% vs 28.6%), and were less likely to believe they would die from PC (3.8% vs 3.9% vs 8.0%). Limitations include the nonrandomised retrospective design and potential recall bias. CONCLUSIONS: Information and participation in decision-making, as well as access to a nurse navigator, are key factors for OSC, regardless of treatment. Men on AS need more information about their treatment and need to participate more in decision-making. OSC was as high among men who had nurse-led follow-up as among men who had doctor-led follow-up. PATIENT SUMMARY: Information about how men with low-risk prostate cancer experience their medical care is limited. In this nationwide population-based study we found that information and participation in decision-making as well as access to a nurse navigator are key factors for satisfaction regardless of treatment. Men who are being closely watched for prostate cancer without immediate curative treatment need more information than they now receive and need to participate more in decision-making than they currently do.
Authors: Lawrence Drudge-Coates; Vitra Khati; Randolph Ballesteros; Clarissa Martyn-Hemphill; Christian Brown; James Green; Ben Challacombe; Gordon Muir Journal: Ecancermedicalscience Date: 2019-12-18
Authors: Oskar Bergengren; Helena Kaihola; Ann-Charlotte Borgefeldt; Eva Johansson; Hans Garmo; Anna Bill-Axelson Journal: Eur Urol Open Sci Date: 2022-02-12
Authors: Sophie D Fosså; Alv A Dahl; Tom Børge Johannesen; Ylva M Gjelsvik; Anne Holck Storås; Tor Å Myklebust Journal: Clin Transl Radiat Oncol Date: 2022-08-06
Authors: Oskar Bergengren; Anna Pia Enblad; Hans Garmo; Ola Bratt; Lars Holmberg; Eva Johansson; Anna Bill-Axelson Journal: Psychooncology Date: 2020-09-01 Impact factor: 3.894
Authors: Rasmus Nilsson; Thomas F Næss-Andresen; Tor Åge Myklebust; Tomm Bernklev; Hege Kersten; Erik Skaaheim Haug Journal: Eur Urol Open Sci Date: 2021-02-03